Gut microbiome and intestinal inflammation in preclinical stages of rheumatoid arthritis.
Autoimmune Diseases
Autoimmunity
Permeability
Rheumatoid Arthritis
Rheumatoid Factor
Journal
RMD open
ISSN: 2056-5933
Titre abrégé: RMD Open
Pays: England
ID NLM: 101662038
Informations de publication
Date de publication:
30 Jan 2024
30 Jan 2024
Historique:
received:
08
08
2023
accepted:
15
01
2024
medline:
1
2
2024
pubmed:
1
2
2024
entrez:
31
1
2024
Statut:
epublish
Résumé
Faecal First-degree relatives of patients with RA (RA-FDRs) from the SCREEN-RA cohort were categorised into four groups: controls, healthy asymptomatic RA-FDRs; high genetic risk, asymptomatic RA-FDRs with two copies of the shared epitope; autoimmunity, asymptomatic RA-FDRs with RA-associated autoimmunity; and symptomatic, clinically suspect arthralgias or untreated new-onset RA.Faecal samples were collected and frozen. 16S sequencing was performed, processed with DADA2 pipeline and Silva database. Cell counts (cytometry) and faecal calprotectin (enzyme-linked immunosorbent assay, ELISA) were also obtained. Microbial community analyses were conducted using non-parametric tests, such as permutational multivariate analysis of variance (PERMANOVA), Wilcoxon and Kruskal-Wallis, or Aldex2. A total of 371 individuals were included and categorised according to their preclinical stage of the disease. Groups had similar age, gender and body mass index. We found no significant differences in the quantitative microbiome profiles by preclinical stages (PERMANOVA, R2=0.00798, p=0.56) and, in particular, no group differences in We could not identify microbiome profiles associated with preclinical stages of RA. Only in a subgroup of individuals with the most pronounced phenotypes did we modestly retrieve the previously reported associations.
Sections du résumé
BACKGROUND
BACKGROUND
Faecal
METHODS
METHODS
First-degree relatives of patients with RA (RA-FDRs) from the SCREEN-RA cohort were categorised into four groups: controls, healthy asymptomatic RA-FDRs; high genetic risk, asymptomatic RA-FDRs with two copies of the shared epitope; autoimmunity, asymptomatic RA-FDRs with RA-associated autoimmunity; and symptomatic, clinically suspect arthralgias or untreated new-onset RA.Faecal samples were collected and frozen. 16S sequencing was performed, processed with DADA2 pipeline and Silva database. Cell counts (cytometry) and faecal calprotectin (enzyme-linked immunosorbent assay, ELISA) were also obtained. Microbial community analyses were conducted using non-parametric tests, such as permutational multivariate analysis of variance (PERMANOVA), Wilcoxon and Kruskal-Wallis, or Aldex2.
RESULTS
RESULTS
A total of 371 individuals were included and categorised according to their preclinical stage of the disease. Groups had similar age, gender and body mass index. We found no significant differences in the quantitative microbiome profiles by preclinical stages (PERMANOVA, R2=0.00798, p=0.56) and, in particular, no group differences in
CONCLUSIONS
CONCLUSIONS
We could not identify microbiome profiles associated with preclinical stages of RA. Only in a subgroup of individuals with the most pronounced phenotypes did we modestly retrieve the previously reported associations.
Identifiants
pubmed: 38296308
pii: rmdopen-2023-003589
doi: 10.1136/rmdopen-2023-003589
pmc: PMC10836359
pii:
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© Author(s) (or their employer(s)) 2024. Re-use permitted under CC BY. Published by BMJ.
Déclaration de conflit d'intérêts
Competing interests: None declared.
Références
Genome Med. 2016 Apr 21;8(1):43
pubmed: 27102666
Arthritis Res Ther. 2023 May 3;25(1):74
pubmed: 37138305
J Clin Med. 2019 May 16;8(5):
pubmed: 31100891
Front Immunol. 2023 Feb 16;14:1117742
pubmed: 36875067
BMJ Open. 2021 Jul 14;11(7):e048409
pubmed: 34261688
Nat Methods. 2016 Jul;13(7):581-3
pubmed: 27214047
Curr Microbiol. 2013 Aug;67(2):170-6
pubmed: 23483307
Elife. 2013 Nov 05;2:e01202
pubmed: 24192039
Ann Rheum Dis. 2012 May;71(5):638-41
pubmed: 22387728
Arthritis Rheum. 2006 Jan;54(1):38-46
pubmed: 16385494
J Clin Med. 2020 Apr 07;9(4):
pubmed: 32272752
PLoS One. 2012;7(2):e30126
pubmed: 22319561
PLoS One. 2013 Apr 22;8(4):e61217
pubmed: 23630581
Nat Rev Rheumatol. 2018 Sep;14(9):542-557
pubmed: 30111803
Arthritis Rheumatol. 2023 Apr;75(4):507-516
pubmed: 36259174
Nat Microbiol. 2018 Jan;3(1):8-16
pubmed: 29255284
Cell Host Microbe. 2021 May 12;29(5):726-739.e5
pubmed: 33957082
Rheumatology (Oxford). 2021 Jul 1;60(7):3380-3387
pubmed: 33313854
Mil Med. 2019 Mar 1;184(Suppl 1):529-536
pubmed: 30901468
Nucleic Acids Res. 2013 Jan;41(Database issue):D590-6
pubmed: 23193283
Sci Transl Med. 2022 Oct 26;14(668):eabn5166
pubmed: 36288282
Biomolecules. 2020 Oct 24;10(11):
pubmed: 33114390
Cell Host Microbe. 2023 May 10;31(5):798-810.e7
pubmed: 37054714
Arthritis Rheumatol. 2021 Jun;73(6):931-942
pubmed: 33314800
Biochem Biophys Res Commun. 2016 Jan 22;469(4):967-77
pubmed: 26718401
Ann Rheum Dis. 2019 May;78(5):590-593
pubmed: 30760471
J Rheumatol. 2008 Aug;35(8):1500-5
pubmed: 18528968
Nat Commun. 2020 Apr 24;11(1):1995
pubmed: 32332732
Br J Rheumatol. 1994 Nov;33(11):1030-8
pubmed: 7981990
Arthritis Rheumatol. 2017 Jan;69(1):114-121
pubmed: 27390077
Lancet Rheumatol. 2020 Jun 25;2(7):e418-e427
pubmed: 33345197
Nat Commun. 2019 Nov 6;10(1):5029
pubmed: 31695033
Gut. 2023 Sep;72(9):1664-1677
pubmed: 36604114
Acta Med Scand. 1968 Nov;184(5):395-402
pubmed: 4308036
Med. 2021 Jul 09;2(7):864-883.e9
pubmed: 34296202
Ann Rheum Dis. 2020 Jan;79(1):103-111
pubmed: 31699813
Front Cell Infect Microbiol. 2023 Jan 18;12:1096211
pubmed: 36741980
Arthritis Rheumatol. 2016 Nov;68(11):2646-2661
pubmed: 27333153
Ann Rheum Dis. 2017 Mar;76(3):491-496
pubmed: 27991858
Arthritis Res Ther. 2023 Mar 2;25(1):32
pubmed: 36864473
Ann Rheum Dis. 2021 Sep;80(9):1158-1167
pubmed: 33926922
ISME Commun. 2023 Jun 10;3(1):59
pubmed: 37301942
Nature. 2017 Nov 23;551(7681):507-511
pubmed: 29143816
Br J Rheumatol. 1987 Oct;26(5):329-33
pubmed: 2889500
Nat Med. 2015 Aug;21(8):895-905
pubmed: 26214836
Sci Adv. 2022 Feb 11;8(6):eabm1511
pubmed: 35148177
Nat Rev Rheumatol. 2022 Oct;18(10):591-602
pubmed: 36068354
Nature. 2020 May;581(7808):310-315
pubmed: 32433607
Nat Microbiol. 2019 Nov;4(11):1826-1831
pubmed: 31209308
Science. 2016 Apr 29;352(6285):560-4
pubmed: 27126039
Microbiome. 2014 Sep 30;2(1):30
pubmed: 27367037
World J Gastroenterol. 2018 Sep 7;24(33):3681-3694
pubmed: 30197475
Cell. 2020 Jan 23;180(2):221-232
pubmed: 31978342